Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Anebulo Pharmaceuticals Inc (NQ: ANEB )

3.910 -0.100 (-2.49%)
Streaming Delayed Price Updated: 2:21 PM EDT, Aug 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,361
Open 3.807
Bid (Size) 3.990 (2)
Ask (Size) 4.250 (2)
Prev. Close 4.010
Today's Range 3.807 - 4.025
52wk Range 2.670 - 7.885
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2022
  
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
  
Via Benzinga

Performance

YTD
-39.38%
-39.38%
1 Month
-7.35%
-7.35%
3 Month
+15.34%
+15.34%
6 Month
-44.30%
-44.30%
1 Year
-46.44%
-46.44%

More News

Read More
Why Is Conagra Brands Dropping By More Than 8%? 43 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Anebulo's ANEB-001 Reduces Cannabis Intoxication In Healthy Participants
Via Benzinga
Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday
Via Benzinga
Why U.S. Stocks Are Trading Lower; Tesla Shares Drop After Price Target Cut At JPMorgan
Via Benzinga
Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Suffering From Acute Cannabinoid Intoxication? Anebulo Is Getting Closer To Investigational New Drug Application
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Anebulo Shares Gain After Positive Topline Results From Mid-stage Study Of Cannabinoid Intoxication Candidate
Via Benzinga
Anebulo Pharmaceuticals Announces Positive Topline Data for ANEB-001 from a Phase 2 Clinical Trial for Acute Cannabinoid Intoxication
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Via Benzinga
Anebulo Pharmaceuticals to Announce Topline Data for ANEB-001 from an Ongoing Phase 2 Clinical Trial for Acute Cannabinoid Intoxication on Tuesday July 5, 2022
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
Via Benzinga
44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More
Via Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
95 Biggest Movers From Yesterday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2022 Financial Results and Recent Updates
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
53 Biggest Movers From Yesterday
Via Benzinga
Anebulo Pharmaceuticals Doses More Than Half of the Subjects in Part A of a Phase 2 Clinical Trial and Provides Guidance on IND Submission
From Anebulo Pharmaceuticals, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.